Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurch...(PROPERTY AND EQUIPMENT NET ...)

Date:12/5/2008

PROPERTY AND EQUIPMENT, NET 1,371 1,253 GOODWILL 2,733 - OTHER ASSETS 359 - Total assets $ 18,303 $ 26,038 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES: Current maturities of capital lease and of long-term loan $ 57 $ 247 Trade payables 919 516 Other accounts payable and accruals 1,134 1,102 Total current liabilities 2,110 1,865 LONG-TERM LIABILITIES: Long-term bank loan and capital lease 48 16 Convertible loan 750 - Deferred revenue 228 228 Accrued severance pay 320 324 Total Long-term Liabilities 1,346 568 COMMITMENTS AND CONTINGENT LIABILITIES SHAREHOLDERS' EQUITY: Share capital: 34 27 Additional paid-in capital 60,733 58,984 Other comprehensive income 131 86 Deficit accumulated during the development stage (46,051) (35,492) Total shareholders' equity 14,847 23,605 Total liabilities and shareholders' equity $ 18,303 $ 26,038 Contact: Media& Investors Ron Kamienchick T: +1-646-509-1893 E: investors@rosettagenomics.com
'/>"/>

SOURCE Rosetta Genomics Ltd Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related biology technology :

1. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
2. /C O R R E C T I O N -- Rosetta Genomics Ltd/
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
4. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
5. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
6. Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
7. Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
8. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
9. Rosetta Genomics Reports Second Quarter 2008 Financial Results
10. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
11. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.